Skip to main content
. Author manuscript; available in PMC: 2019 May 31.
Published in final edited form as: Bioconjug Chem. 2018 Jun 29;29(7):2161–2169. doi: 10.1021/acs.bioconjchem.8b00285

Table 2:

Summary of multivalent nanoparticles (NPs) with phage-derived targeting peptides.

Indication Target Targeting Peptide Nanostructure and size Result Ref
Post-assembly peptide conjugation
Femur fracture in murine model Tartrate-resistant acid phosphatase6 TPLSYLKGLV TVG Micelle formation of PSMA-PS diblock copolymers by solvent exchange; carbodiimide peptide conjugation to form 50 nm micelles Two-fold greater fracture accumulation relative to scrambled control in vivo. Fracture-specific drug delivery expedited healing and improved bone mechanical properties. 62
Liver-colonizing Colon 26 NL-17 cells in murine model Human endothelial progenitor cells (hEPCs) ASSHN DPPC, CHOL, and DSPE-PEG2000-MAL liposomes modified with ASSHNC peptide to form 101 nm particles Intratumoral distribution in vivo. Tumor-specific doxorubicin delivery reduced tumor volume more than untargeted control. 63
Neuroblastoma xenografts in nude mice APA25 and APN30 CPRECES and CNGRC Dual conjugation of peptides to HSPC, CHOL, DSPE-PEG2000-NH2 liposomes via BS3 cross-linker to form 90–115 nm liposomes Superior tumor uptake of dual-targeted liposomes in vivo. Tumor-specific doxorubicin delivery led to tumor vasculature-associated endothelial cell and pericyte death and significantly greater life spans of mice. 64
Lung cancer xenografts in nude mice Tumors responding to VEGF inhibitor treatment HVGGSSV65 100 nm liposomes composed of DSPC, CHOL, and MAL-PEG2000-DSPE modified with cysteine-functional peptide Greater accumulation in irradiated tumors and time-dependent increase in doxorubicin delivery to tumors in vivo. Tumor-specific doxorubicin delivery induced apoptosis and delayed tumor growth. 66
Drug delivery through BBB Brain TGNYKALHP HNG Cysteine-modified peptide conjugated to MAL-PEG-PLA micelles to form 110–120 nm particles Uptake by brain-derived endothelial cells in vitro. High brain-to-liver and brain-to-spleen for TGN-NPs in vivo. Dye delivery to brain ~2- to 4-fold greater than controls. 67
Breast carcinoma xenografts in nude mice, glioma murine model Glucose-regulated protein GRP78 GIRLRG Cysteine-modified peptide conjugated to allyl-functional poly(ester) NPs Accumulation in irradiated tumors in vivo. Tumor-specific paclitaxel delivery resulted in 50% greater apoptosis and delayed tumor tripling time by 55 days. 68
Left carotid injury in rats Human collagen IV KLWVLPK Cysteine-modified peptide conjugated to shell MAL-PEG-DSPE / core PLA-paclitaxel liposomes to form 60 nm particles. Exhibited 10–12 day drug release and binding to injured aortas (percutaneous angioplasty) in vitro. Spatiotemporally control distribution to injured vessels in vivo. 69
Pre-assembly peptide conjugation
Neuroblastoma, lung, ovarian, and prostate tumor xenografts in nude mice APN30 CGNGRGGVR SSSRTPSDKY C Peptide conjugated to DSPE-PEG2000-MAL and combined with HSPC, CHOL, and DSPE-PEG2000 to form 90–115 nm liposomes Dox-loaded NGR-liposomes exhibited high tumor uptake in vivo, tumor volumes were reduced, and mice achieved longer survival. 7072
Glioblastoma xenograft in nude mice VAV3 receptor73 SSQPFWS MAL-PEG-PLA modified with SSQPFWSC peptides to form 23 nm micelles High cellular uptake efficiency and tumor spheroid penetration in vitro. Tumor vasculature accumulation in vivo. Tumor-specific paclitaxel delivery inhibited tumor growth more than untargeted control. 74
Carotid artery ligation atherosclerosis murine model Filamin-A in atheroprone regions of disturbed blood flow GSPREYTSY MPH Peptide conjugated to DPHE and combined with DPPC to form 64 nm liposomes Five-fold greater accumulation in disturbed flow regions in vivo. Artery-specific BH4 delivery decreased superoxide concentration and reduced plaque burden. 75
Liver-colonizing Colon 26 NL-17 cells and Meth A sarcoma in murine model Angiogenic vessels in dorsal air sac murine model APRPG Stearoyl-peptide combined with DSPC and CHOL to form 100 nm Liposomes Binding to human islet cell and glioblastoma tumors in vitro. Time-dependent tumor accumulation in vivo. Tumor vessel-specific doxorubicin slowed tumor growth and increased life span. 76
Carotid artery Ligation atherosclerosis murine model Non-muscle myosin heavy chain IIA on endothelial cells in atheroprone vasculature CLIRRTSIC Peptide conjugated to NHS-PEG-MAL, then MAL reacted with disulfide-Crosslinked branched PEI. Complexed with siRNA to form 200 nm polyplexes Binding to endothelial cells exposed to oscillatory shear stress in vitro. Selective binding to and gene knockdown in regions of disturbed flow in vivo. 77
RIP-Tag2 transgenic pancreatic cancer murine model Pancreatic islet tumor78, Potentially Frizzled-5 Receptor CKAAKN Peptide conjugated to 6-(maleimidyl)-Hexanoic acid(trisnor-squalenylidene)-hydrazide. SQ-CKAAKN mixed with SQ-gemcitabine to form 130–170 nm NPs Binding to secreted frizzled related protein-4 and low complement activation in vitro. Tumor-specific gemcitabine delivery reduced tumor burden by 30% and vessel area by 60% compared to untargeted. 79
Gene delivery to the brain Brain67 TGNYKALHP HNG Peptide conjugated to MAL-PEG-pDMAEMA. Complexed with DNA to form 80 nm micelles Uptake by brain capillary endothelial cells in vitro. Brain-specific DNA delivery qualitatively enhanced gene expression in the brain relative to untargeted. 80

Table 2 Abbreviations: APA, Aminopeptidase A. APN, Aminopeptidase N. BBB, Blood-brain barrier. BH4, Tetrahydrobiopterin. BS3, bis(sulfosuccinimidyl)suberate. CD, Cluster of differentiation. CHOL, Cholesterol. DOTAP, 1,2-dioleoyl-3-trimethylammonium-propane. DPHE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-hexanoylamine. DPPC, Dipalmitoylphosphatidylcholine. DPPG, 1,2-dipalmitoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]. DSPC, 1,2-distearoyl-sn-glycero-3-phosphocholine. DSPE, 1,2-distearoylphosphatidylethanolamine. ePC, L-α-phosphatidylcholine. HSPC, Hydrogenated soybean phosphatidylcholine. MAL, Maleimide. MCF, Michigan Cancer Foundation. NHS, N-hydroxysuccinimide. pDMAEMA, poly(2-(dimethylamino) ethyl methacrylate). PE, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine. PEG, poly(ethylene glycol). PEI, poly(ethyleneimine). PLA, poly(lactic acid). PSMA, poly(styrene-alt-maleic anhydride). PS, poly(styrene). SPDP, N-succinimidyl 3-(2-pyridyldithio)proprionate. SQ, squalene. VEGF, endothelial growth factor.